3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
116
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Recurrence
17
Burkitt Lymphoma
14
Lymphoma, Large B-Cell, Diffuse
8
Neoplasms
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms, Plasma Cell
6
Lymphoma
6
Leukemia, Biphenotypic, Acute
5
Immunoglobulin Light-chain Amyloidosis
5
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Lymphoma, Non-Hodgkin
4
Lymphoma, B-Cell
4
Waldenstrom Macroglobulinemia
3
Neoplasm Metastasis
3
Nausea
3
Lung Neoplasms
3
Leukemia
3
Smoldering Multiple Myeloma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Paraproteinemias
2
Ovarian Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Down Syndrome
2
Interventions
fludarabine
2
durvalumab
2
Cyclophosphamide
2
ruxolitinib
1
repotrectinib
1
ponatinib
1
pembrolizumab
1
gilteritinib
1
fludarabine phosphate
1
cemiplimab
1
atezolizumab
1
Whole-Body Irradiation
1
Tacrolimus
1
Peripheral Blood Stem Cell Transplantation
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Nivolumab
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Immunotherapy
1
Idarubicin
1
Granulocyte Colony-Stimulating Factor
1
Docetaxel
1
Cytarabine
1
Cisplatin
1
CPI-0610
1
Busulfan
1
Bone Marrow Transplantation
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Histologic Type
×
Dexamethasone
×
90 days
×
Clear all
No trials found.